Prenetics Group Limited (PRE)
NASDAQ:PRE
Want to see PRE full AI Analyst Report?
PRE Stock Chart & Stats
$17.83
-$0.22(-3.97%)
At close: 4:00 PM EST
$17.83
-$0.22(-3.97%)
Day’s Range― - ―
52-Week Range$7.18 - $23.63
Previous CloseN/A
Volume5.03K
Average Volume (3M)276.59K
Market Cap
$316.88M
Enterprise Value$281.98M
Total Cash (Recent Filing)$106.03M
Total Debt (Recent Filing)$457.00K
Price to Earnings (P/E)―
Beta0.25
Next Earnings
Sep 11, 2026EPS Estimate
-0.71Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.58
Shares Outstanding15,247,465
10 Day Avg. Volume237,813
30 Day Avg. Volume276,590
Financial Highlights & Ratios
PEG Ratio0.22
Price to Book (P/B)1.27
Price to Sales (P/S)2.40
P/FCF Ratio-10.05
Enterprise Value/Market Cap0.89
Enterprise Value/Revenue2.48
Enterprise Value/Gross Profit4.25
Enterprise Value/Ebitda-5.46
Forecast
1Y Price Target
$33.00Price Target Upside85.08% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-3.17
Revenue Forecast (FY)$201.42M
Bulls Say, Bears Say
Bulls Say
Subscription-led Revenue GrowthRapidly growing subscription revenue creates predictable, recurring cash flows and higher visibility into future demand. With ~82k active subscribers and servings rising, recurring consumption underpins LTV expansion and supports scalable unit economics as the business internationalizes over the next 2–6 months.
Improving Gross Margins And Unit EconomicsMaterial margin expansion driven by scale manufacturing, favorable mix toward subscriptions, packaging/fulfillment improvements and rising AOV strengthens the path to profitability. Sustained higher gross margins increase operating leverage and make future marketing investments more economically efficient.
Low Leverage And Strengthened LiquidityA clean, low-debt balance sheet and large liquid resources materially reduce near-term refinancing risk and provide capital to fund international scaling, new SKUs and marketing experiments. This financial flexibility supports multi-quarter execution without immediate dependence on external capital markets.
Bears Say
Negative Operating And Free Cash FlowConsistent negative operating and free cash flow indicates the business still consumes cash to scale. Even with liquidity today, persistent cash burn can force future dilution or spending cuts if growth or conversion deteriorates, making funding and margin delivery a multi-quarter execution risk.
High Marketing Spend Pressuring EBITDADeliberate, large marketing investment is diluting near-term profitability and widened adjusted EBITDA losses. If marketing productivity or paid channels underperform, the company could face stretched cash consumption before cohort payback improvements fully realize across geographies.
Customer Acquisition ConcentrationHeavy reliance on a single paid channel raises conversion and cost risk as platform dynamics change. Early, low-scale tests on TikTok/YouTube/AppLovin leave the firm exposed to CPM or policy shifts; durable growth depends on successful diversification of acquisition channels.
Prenetics Group News
PRE FAQ
What was Prenetics Group Limited’s price range in the past 12 months?
Prenetics Group Limited lowest stock price was $7.17 and its highest was $23.63 in the past 12 months.
What is Prenetics Group Limited’s market cap?
Prenetics Group Limited’s market cap is $316.88M.
When is Prenetics Group Limited’s upcoming earnings report date?
Prenetics Group Limited’s upcoming earnings report date is Sep 11, 2026 which is in 74 days.
How were Prenetics Group Limited’s earnings last quarter?
Prenetics Group Limited released its earnings results on May 14, 2026. The company reported -$1.36 earnings per share for the quarter, missing the consensus estimate of -$1.017 by -$0.343.
Is Prenetics Group Limited overvalued?
According to Wall Street analysts Prenetics Group Limited’s price is currently Undervalued.
Does Prenetics Group Limited pay dividends?
Prenetics Group Limited pays a Quarterly dividend of $0.7 which represents an annual dividend yield of N/A. See more information on Prenetics Group Limited dividends here
What is Prenetics Group Limited’s EPS estimate?
Prenetics Group Limited’s EPS estimate is -0.71.
How many shares outstanding does Prenetics Group Limited have?
Prenetics Group Limited has 15,247,465 shares outstanding.
What happened to Prenetics Group Limited’s price movement after its last earnings report?
Prenetics Group Limited reported an EPS of -$1.36 in its last earnings report, missing expectations of -$1.017. Following the earnings report the stock price went up 0.114%.
Which hedge fund is a major shareholder of Prenetics Group Limited?
Currently, no hedge funds are holding shares in PRE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Prenetics Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$33.00 (85.08% Upside)
$33.00 (85.08% Upside)
Blogger Sentiment
Bullish
PRE Sentiment 70%
Sector Average ―
Sector Average ―
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.0%
Last 30 Days ▼ 3.7%
Last 30 Days ▼ 3.7%
Technicals
SMA
Positive
20 days / 200 days
Momentum
109.22%
12-Months-Change
Fundamentals
Return on Equity
-46.74%
Trailing 12-Months
Asset Growth
-14.07%
Trailing 12-Months
Company Description
Prenetics Group Limited
As an investment holding company, Prenetics Global Limited specializes in providing diagnostic and genetic testing services. Its comprehensive product line features CircleDNA, a consumer-oriented genetic analysis solution, and the Circle HealthPod, an advanced health monitoring device. The Circle HealthPod facilitates rapid COVID-19 detection through nucleic acid amplification technology, suitable for both professional point-of-care and personal at-home use. Additionally, the company offers ColoClear, a non-invasive FIT-DNA screening test for colorectal cancer, and Circle SnapShot, a readily available at-home blood testing kit. Other diagnostic solutions in their portfolio include Circle Medical, Circle One, and F1x/Fem. Prenetics Global Limited was founded in 2014 and maintains its headquarters in Quarry Bay, Hong Kong.
PRE Company Deck
PRE Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a strongly positive operational narrative: very high revenue growth, significant improvement in gross margins, rapid cohort/LTV acceleration, healthy subscriber growth and consumption, raised guidance, and substantial cash resources after a Bitcoin sale. Management acknowledged near-term EBITDA losses driven by deliberate marketing investments to scale international quarterly subscriptions and noted preliminary accounting items pending close. Execution risks remain around channel diversification, potential reporting clarity, and delivering new product launches. On balance the positive growth, improving unit economics, and strong cohort metrics outweigh the near-term losses and execution items.View all PRE earnings summariesPRE Stock 12 Month Forecast
Average Price Target
$33.00
▲(85.08% Upside)
Technical Analysis
Ownership Overview
0.68% Insiders
0.04% Mutual Funds
7.00% Other Institutional Investors
92.07% Public Companies and
Individual Investors